As in the B-ALL competition experiment, we mixed fluorescently labeled GL261 cells deficient for Ifngr1 with isogenic WT control cells and tracked the relative behavior of each cell type following injection of anti-hCD19 CAR-T cells. This evidence concerns the gene IFNGR1 and precursor B-cell acute lymphoblastic leukemia.